FDA regulatory status and what it means for patients The regulatory landscape for compounded semaglutide, including the glycine B12 blend, has been turbulent
Thymosin beta-4 and cardiac repair
The FDA recently warned consumers not to use Captomer or Captomer-250 by Thorne Research, which contained DMSA
However, in some instances, paradoxically, binding of the antibodies at subneutralizing concentrations to non-critical sites of the virion can result in non-neutralization of the virion that may lead to virion entry and invasion into certain cell types via antibody Fc region present on the carboxyl-terminal domain of antibody with Fc gamma receptor IIa (FcRIIa)-expressing phagocytic cells like the monocytes, macrophages, or through interaction with complement receptors contributing in the enhancement of infection, a process known as antibody-dependent enhancement 37,38,39,40,41 during these instances, the binding of antibodies to these non-critical sites leaves the virus with retainment of its infectivity 37
Alamdari, N., et al
10.3389/fpsyt.2021.813590 129